Skip to content
healthcare.dev

Natesto nasal gel

NDC 42667-5511, testosterone, gel, metered, from Acerus Pharmaceuticals Corporation.

Product NDC
42667-5511
Status
Listed
Labeler
Acerus Pharmaceuticals Corporation
Dosage form
GEL, METERED
Route
NASAL
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
NDA
Application
NDA205488
DEA schedule
CIII
Request
curl https://api.healthcare.dev/v1/drugs/ndc/42667-5511 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • TESTOSTERONE5.5 mg/.122g

Pharmacologic classes

Androgen Receptor Agonists [MoA]; Androgen [EPC]; Androstanes [CS]

Package NDCNDC-11Package
42667-5511-1426675511011 APPLICATOR in 1 BOX (42667-5511-1) / 11 g in 1 APPLICATOR

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/dea6bed1-eaca-11e3-ac10-0800200c9a66
  • NADAC price for package 42667551101

    GET /v1/drugs/nadac/42667551101

Use it

Look up 42667-5511 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/42667-5511 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 42667-5511. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.